Notice of Correction for Announcement of Requirements and Registration for: “Harnessing Insights From Other Disciplines To Advance Drug Abuse and Addiction Research” Challenge, 31402 [2015-13348]
Download as PDF
31402
Federal Register / Vol. 80, No. 105 / Tuesday, June 2, 2015 / Notices
including packaging grant
announcements and application kits.
Makes recommendations to the
Director/NIDILRR regarding allocation
of NIDILRR program funds for current
and future budget years. Coordinate and
collaborates with Office of Research
Sciences program staff in the
preparation of the annual spending plan
and facilitate the implementation of the
plan to ensure compliance with
established departmental guidance.
Provides administrative support in the
monitoring of grants and cooperative
agreements, and facilitates the
administrative execution of interagency
agreements.
Administers NIDILRR evaluation
activities to improve the effectiveness of
NIDILRR’s research activities. This
includes collaboration with NIDILRR’s
senior management to define and
facilitate the conduct of analyses of
program and budget data as well as
focused, special program evaluation
activities. In its evaluation function, it
coordinates with CPE to prepare
planning and evaluation documents
required by ACL, HHS, OMB and
Congress.
II. Delegations of Authority: All
delegations and re-delegations of
authority made to officials and
employees of affected organizational
components will continue in them or
their successors pending further redelegations.
III. Funds, Personnel and Equipment:
Transfer of organizations and functions
affected by this reorganization shall be
accompanied in each instance by direct
and support funds, positions, personnel,
records, equipment, supplies and other
resources.
Dated: May 27, 2015.
Sylvia M. Burwell,
Secretary.
[FR Doc. 2015–13351 Filed 6–1–15; 8:45 am]
BILLING CODE 4150–04–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
asabaliauskas on DSK5VPTVN1PROD with NOTICES
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
VerDate Sep<11>2014
17:26 Jun 01, 2015
Jkt 235001
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel;
Mitochondrial ROS and Aging.
Date: July 9, 2015.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, Suite 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Elaine Lewis, Ph.D.,
Scientific Review Branch, National Institute
On Aging, Gateway Building, Suite 2C212,
MSC–9205, 7201 Wisconsin Avenue,
Bethesda, MD 20892, 301–402–7707,
elainelewis@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: May 27, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–13149 Filed 6–1–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Correction for
Announcement of Requirements and
Registration for: ‘‘Harnessing Insights
From Other Disciplines To Advance
Drug Abuse and Addiction Research’’
Challenge
The National Institutes of Health
(NIH) is correcting a notice previously
published in the Federal Register on
May 26, 2015 (80 FR 30084) and titled
‘‘Announcement of Requirements and
Registration for: ‘‘Harnessing Insights
From Other Disciplines To Advance
Drug Abuse and Addiction Research’’
Challenge.’’ The notice announced a
National Institute on Drug Abuse
(NIDA) challenge soliciting ideas on
how to adapt specialized knowledge
from other disciplines to inform new
directions and discoveries in drug abuse
and addiction research.
NIH is amending the submission date
for the challenge from June 22, 2015 to
June 30, 2015, the Judging period from
June 23, 2015–July 17, 2015 to July 1,
2015–July 24, 2015, and winners
announced date from July 30, 2015 to
August 6, 2015.
For further information about the
Challenge, please contact Emily
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Einstein, Ph.D. Science Policy Branch,
NIDA, Phone 301–443–6071, email:
emily.einstein@nih.gov.
Dated: May 27, 2015.
Nora D. Volkow,
Director, National Institute on Drug Abuse
National Institutes of Health.
[FR Doc. 2015–13348 Filed 6–1–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Announcement for Request for
Comment for: Antimicrobial
Resistance Rapid, Point-of-Care
Diagnostic Test Challenge
Authority: 15 U.S.C. 3719
The U.S. Department of
Health and Human Services (HHS)
intends to hold a prize competition in
which up to $20 million will be made
available, subject to the availability of
funds, for the delivery of one or more
successful rapid point-of-care
diagnostics that may be used by health
care providers to identify bacterial
infections. The National Institutes of
Health (NIH) and the Biomedical
Advanced Research and Development
Authority (BARDA) are sponsoring the
prize competition, and seek public
comments regarding the technical
criteria and performance characteristics
of the diagnostic(s) for which the
prize(s) will be offered.
DATES: Submission Period begins June 2,
2015, 9:00 a.m. EST. Submission Period
ends 5 p.m. EST July 17, 2015.
ADDRESSES: Comments can be sent to
https://www.challenge.gov.
FOR FURTHER INFORMATION CONTACT:
Robert W. Eisinger, Ph.D., National
Institutes of Health, Division of Program
Coordination, Planning, and Strategic
Initiatives, Telephone: 301–496–2229,
Email:Robert.eisinger@nih.gov.
SUPPLEMENTARY INFORMATION: On
September 18, 2014, the President
issued Executive Order 13676 on
Combating Antibiotic-Resistant Bacteria
(https://www.whitehouse.gov/the-pressoffice/2014/09/18/executive-ordercombating-antibiotic-resistant-bacteria)
and the Antimicrobial Resistance
Challenge was called for in the
accompanying White House Fact Sheet
https://www.whitehouse.gov/the-pressoffice/2014/09/18/fact-sheet-obamaadministration-takes-actions-combatantibiotic-resistan). The development
and use of rapid, point-of-care, and
innovative diagnostic tests for
SUMMARY:
E:\FR\FM\02JNN1.SGM
02JNN1
Agencies
[Federal Register Volume 80, Number 105 (Tuesday, June 2, 2015)]
[Notices]
[Page 31402]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-13348]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Correction for Announcement of Requirements and
Registration for: ``Harnessing Insights From Other Disciplines To
Advance Drug Abuse and Addiction Research'' Challenge
The National Institutes of Health (NIH) is correcting a notice
previously published in the Federal Register on May 26, 2015 (80 FR
30084) and titled ``Announcement of Requirements and Registration for:
``Harnessing Insights From Other Disciplines To Advance Drug Abuse and
Addiction Research'' Challenge.'' The notice announced a National
Institute on Drug Abuse (NIDA) challenge soliciting ideas on how to
adapt specialized knowledge from other disciplines to inform new
directions and discoveries in drug abuse and addiction research.
NIH is amending the submission date for the challenge from June 22,
2015 to June 30, 2015, the Judging period from June 23, 2015-July 17,
2015 to July 1, 2015-July 24, 2015, and winners announced date from
July 30, 2015 to August 6, 2015.
For further information about the Challenge, please contact Emily
Einstein, Ph.D. Science Policy Branch, NIDA, Phone 301-443-6071, email:
emily.einstein@nih.gov.
Dated: May 27, 2015.
Nora D. Volkow,
Director, National Institute on Drug Abuse National Institutes of
Health.
[FR Doc. 2015-13348 Filed 6-1-15; 8:45 am]
BILLING CODE 4140-01-P